IP Verse

Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation

Patent No. EP3019153 (titled "Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation") was filed by Chiesi Farmaceutici on Jul 10, 2014. The application was issued on Sep 5, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJun 5, 2019ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3019153

CHIESI FARMACEUTICI
Application Number
EP14747855A
Filing Date
Jul 10, 2014
Status
Granted And Under Opposition
Aug 3, 2018
Publication Date
Sep 5, 2018
External Links
Slate, Register , Google Patents